Kirin leans into health products and drugs, pouring in $900m - Nikkei Asia
Kirin leans into health products and drugs, pouring in $900m Nikkei Asia
Healthcare, Pharmaceutical, Biotechnology, Clinical Research & MedTech Industry News
Kirin leans into health products and drugs, pouring in $900m Nikkei Asia
Iterative Health Acquires Three Texas Cardiology Sites from NextStage Clinical Research Contract Pharma
EMA changes tune, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population Fierce Pharma